Journals / Anadolu Kardiyoloji Dergisi / 2013 / Cilt: 13 - Sayı: 6

Almanac 2013: novel non-coronary cardiac interventions

Almanac 2013: Koroner olmayan girişimlerde yenilikler

Pages
622–631
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review explains the basic principles of these procedures, the most important clinical evidence, and also provides additional recent clinical data on each of these them.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Recent innovations in interventional cardiology have dramatically expanded the therapeutic options for patients with cardiac conditions.
📊
Key Findings & Data:Interventional cardiology is no longer limited to the treatment of coronary artery disease but allows also treatment of valvular disease, stroke prevention, hypertension, etc.
💡
Conclusion & Impact:This review explains the basic principles of these procedures, the most important clinical evidence, and also provides additional recent clinical data on each of these them.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Recent innovations in interventional cardiology have dramatically expanded the therapeutic options for patients with cardiac conditions. Interventional cardiology is no longer limited to the treatment of coronary artery disease but allows also treatment of valvular disease, stroke prevention, hypertension, etc. One of the most important new treatment options is the percutaneous treatment for aortic valve stenosis (trans- catheter aortic valve implantation), since aortic valve disease is a rather common problem in elderly patients, with many of them at high risk for surgery. Similarly, mitral regurgitation is often associated with comorbidities which make surgery high risk. The MitraClip is a promising percutaneous alternative to surgical valve repair or replacement. Other procedures discussed in this review are the percutaneous left atrial appendage closure as a non-pharmacologic therapy to prevent strokes, and renal denervation for resistant hypertension. This review explains the basic principles of these procedures, the most important clinical evidence, and also provides additional recent clinical data on each of these them.

Özet

Recent innovations in interventional cardiology have dramatically expanded the therapeutic options for patients with cardiac conditions. Interventional cardiology is no longer limited to the treatment of coronary artery disease but allows also treatment of valvular disease, stroke prevention, hypertension, etc. One of the most important new treatment options is the percutaneous treatment for aortic valve stenosis (trans- catheter aortic valve implantation), since aortic valve disease is a rather common problem in elderly patients, with many of them at high risk for surgery. Similarly, mitral regurgitation is often associated with comorbidities which make surgery high risk. The MitraClip is a promising percutaneous alternative to surgical valve repair or replacement. Other procedures discussed in this review are the percutaneous left atrial appendage closure as a non-pharmacologic therapy to prevent strokes, and renal denervation for resistant hypertension. This review explains the basic principles of these procedures, the most important clinical evidence, and also provides additional recent clinical data on each of these them.

🔖

Cite This Article

FRANZEN, O., MEIER, P., LANSKY, J. A. (2022). Almanac 2013: novel non-coronary cardiac interventions. Anadolu Kardiyoloji Dergisi, Cilt: 13 - Sayı: 6, 622–631. https://ajindex.com/articles/436610

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Meier P Timmis A. Almanac 2012: interventional cardiology. Anadolu Kardiyol Derg 2012; 13: 91-101
  2. Lloyd-Jones DM, Wang TJ, Leip EP et al. Lifetime risk for develop- ment of atrial fibrillation: the Framingham Heart Study. Circulation 2004; 110: 1042-6. [CrossRef] 3. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-429. [CrossRef] 4. Gallagher AM, Rietbrock S, Plumb J, et al. Initiation and persis- tence of warfarin or aspirin in patients with chronic atrial fibrilla- tion in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost 2008; 6: 1500-6. [CrossRef] 5. Garcia-Fernandez MA, Perez-David E, Quiles J, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol 2003; 42: 1253-8. [CrossRef] 6. MEMBERS WC, Bonow RO, Carabello BA, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118: e523-661. [CrossRef] 7. Khattab AA, Meier B. Transcatheter left atrial appendage exclusion, gold or fool’s gold? Eur Heart J Suppl 2010; 12: E35-40. [CrossRef] 8. Sousa JE, Costa MA, Tuzcu EM, et al. New frontiers in interven- tional cardiology. Circulation 2005; 111: 671-81. [CrossRef] 9. Munkholm-Larsen S, Cao C, Yan TD, et al. Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review. Heart 2012; 98: 900-7. [CrossRef] 10. Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferior- ity trial. Lancet 2009; 374: 534-42. [CrossRef] 11. Reddy VY, Doshi SK, Sievert H, et al. Percutaneous left atrial appendage closure for stroke proph